Search Results
158 items found for "IJzerman AP"
- Ep 65 with Dr. Sudarshan Rajagopal
Lefkowitz , where his research focused on biased agonism, with the development of approaches to quantify
- Ep 76 with Steve McCloskey
Steve’s work is focused on emerging technologies applied to Science, Technology, Engineering, and Mathematics
- Ep 52 with Dr. Benjamin Myers
mechanisms employed by these atypical 7-transmembrane receptors, combining biochemical and structural approaches
- Ep 157 with Dr. Nagarajan Vaidehi
her contributions in developing constrained molecular dynamics simulation methods with emphasis on application
- Ep 57 with Dr. Peter Robert Banks
His responsibilities include the management of the company’s applications team and providing scientific
- Ep 53 with Dr. Timo De Groof
in the In Vivo Cellular and Molecular Imaging (ICMI) group that is focused on translational/clinical applications previous GPCR experience with his current focus to set up his own research line focusing on translational applications
- FAQ | Dr. GPCR Ecosystem
Why do I need to fill out a form and wait for approval?
- Suppor Dr. GPCR Ecosystem
We truly appreciate your commitment to our cause and are grateful for your contribution.
- GPCR Courses
Terry Kenakin Applying Pharmacology to Drug Discovery Watch recording Dr. Why do I need to fill out a form and wait for approval?
- Retreat | Dr. GPCR Ecosystem
button at the bottom of the page and Sign Up by submitting your info - Please note that membership approval We thoroughly review each application to ensure that they’re part of the GPCR field. - To expedite the process of your application, we suggest adding "GPCR Retreat" in the "Area of Expertise" field. - Once your application is approved, you will receive an email notification.
- Atypical Structure and Function of Typical Chemokine Receptors
Although symptoms of GRIN disorder appear very early in childhood, it can take years to reach the right The Ramsey lab uses a combination of biochemical and behavioural approaches to understand the many roles
- Session V | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Langenhan Apr 2016 – Nov 2022 PhD candidate, University Leipzig, Group of Prof. adhesion domains within the structure and hints at a model where the compact module could be pulled apart solvent-accessibility of the catalytically active GPS triad HL|S/T, however classical molecular dynamics approaches Using a multiscale QM/MM approach - combining computational quantum mechanics with classical molecular
- The binding mechanism of an anti-multiple myeloma antibody to the human GPRC5D homodimer
identify a distinct head-to-head homodimer arrangement and interface mainly involving TM4, setting it apart
- Small-molecule targeting of GPCR-independent noncanonical G-protein signaling in cancer
Small-molecule targeting of GPCR-independent noncanonical G-protein signaling in cancer Published date April G-protein-coupled receptors (GPCRs) is a quintessential mechanism of cell signaling widely targeted by clinically approved
- Leukotriene B4 receptor 2 governs macrophage migration during tissue inflammation
Moreover, we established the applicability of our zebrafish findings to mammals by showing that macrophages
- Inhibition of Relaxin Autocrine Signaling Confers Therapeutic Vulnerability in Ovarian Cancer
This approach has provided insight into novel drivers resulting from the widespread gene copy number
- Trainee Symposium II
I employ a multidisciplinary approach that combines molecular pharmacology, biochemical assays, and biophysical
- Elucidation of active components and target mechanism in Jinqiancao granules for the treatment of prostatitis and benign prostatic hyperplasia
A dynamic mass redistribution technique was applied to evaluate compounds on four GPCRs.
- The Effect of Cancer-Associated Mutations on Ligand Binding and Receptor Function - A Case for the 5-HT2C Receptor
Besides regulating mood, appetite, and reproductive behavior, it has been identified as a potential target
- G Protein-coupled Receptor-mediated Membrane Targeting of PLCγ2 is Essential for Neutrophil Chemotaxis
Receptor-mediated Membrane Targeting of PLCγ2 is Essential for Neutrophil Chemotaxis Published date April
- Mechanistic exploration of bioactive constituents in Gnetum gnemon for GPCR-related cancer treatment through network pharmacology and molecular docking
Integrated approach combined network pharmacology and molecular docking to identify and validate the This study presents a novel approach for comprehending the therapeutic mechanisms of GG-derived active compounds and thereby paving the way for their prospective clinical applications in the field of cancer
- Session VII | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
newly generated adhesion GPCR receptors in Drosophila as a model organism for future pharmacological applications research focuses on the relevance of aGPCRs in physiology and signaling using both in vitro and in vivo approaches
- Involvement of Protease-Activated Receptor2 Pleckstrin Homology Binding Domain in Ovarian Cancer: Expression in Fallopian Tubes and Drug Design
Authors Jeetendra Kumar Nag , Sorina Grisaru-Granovsky , Shunit Armon , Tatyana Rudina , Priyanga Appasamy
- A virally encoded GPCR drives glioblastoma through feed-forward activation of the SK1-S1P1 signaling axis
Inhibition of S1P signaling abrogated the proliferative and anti-apoptotic effects of US28.
- Evolutionary diversity of CXCL16-CXCR6: Convergent substitutions and recurrent gene loss in sauropsids
To understand the evolution and diversity of CXCL16-CXCR6 across vertebrates, we compared approximately
- Mutation Patterns Predict Drug Sensitivity in Acute Myeloid Leukemia
Statistical approaches and machine learning models were applied to identify signatures for drug response The application of single-cell genomic sequencing unveiled the co-occurrence of variants at the individual
- LP2, a cyclic angiotensin-(1-7) analog extended with an N-terminal D-lysine, impairs growth of patient-derived xenografts of colorectal carcinoma in mice
inhibition indicated that LP2-mediated AT 2 R stimulation inhibited PI3K/AKT/mTOR which resulted in apoptosis
- Unveiling G-protein coupled receptors as potential targets for ovarian cancer nanomedicines: from RNA sequencing data analysis to in vitro validation
2024 Abstract "Genetic heterogeneity in ovarian cancer indicates the need for personalised treatment approaches To address the genetic heterogeneity of ovarian cancer, a future personalised approach could include supporting and emphasising the need for the future development of case-to-case personalised targeting approaches